IBB vs XYLD
iShares Biotechnology ETF vs Global X S&P 500 Covered Call ETF
- • IBB has the lower expense ratio at 0.44% vs 0.60% for XYLD.
- • XYLD pays a higher dividend yield (9.29%).
Side-by-side metrics
| Metric | IBB | XYLD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.60% |
Dividend yield Trailing 12-month yield. | 0.22% | 9.29% |
AUM Assets under management — bigger funds are typically more liquid. | $9.09B | $3.20B |
YTD return | 16.44% | 6.39% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 0.41 |
P/E ratio | 24.89 | 27.04 |
Last price | $197.34 | $41.14 |
Inception | — | — |
Issuer | iShares | Global X |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
XYLD top holdings
| NVDA | NVIDIA Corp | 7.59% |
| AAPL | Apple Inc | 6.66% |
| MSFT | Microsoft Corp | 4.34% |
| AMZN | Amazon.com Inc | 3.65% |
| GOOGL | Alphabet Inc Class A | 3.28% |
| AVGO | Broadcom Inc | 2.80% |
| GOOG | Alphabet Inc Class C | 2.62% |
| MU | Micron Technology Inc | 2.04% |
| META | Meta Platforms Inc Class A | 1.93% |
| TSLA | Tesla Inc | 1.86% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About XYLD
XYLD (Global X S&P 500 Covered Call ETF) is S&P 500 covered call strategy for enhanced income. Managed by Global X, the fund carries $3.2B in assets under management, an expense ratio of 0.60%, a dividend yield of 9.29%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.6% of the portfolio. Real Estate is the fund's largest sector exposure at 1.8%.